scispace - formally typeset
S

Stefanie Dimmeler

Researcher at Goethe University Frankfurt

Publications -  618
Citations -  88185

Stefanie Dimmeler is an academic researcher from Goethe University Frankfurt. The author has contributed to research in topics: Endothelial stem cell & Progenitor cell. The author has an hindex of 147, co-authored 574 publications receiving 81658 citations. Previous affiliations of Stefanie Dimmeler include St. Vincent's Institute of Medical Research & German Cancer Research Center.

Papers
More filters
Journal ArticleDOI

Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation

TL;DR: It is demonstrated that the serine/threonine protein kinase Akt/PKB mediates the activation of eNOS, leading to increased NO production, and represents a novel Ca2+-independent regulatory mechanism for activation ofeNOS.
Journal ArticleDOI

Endothelial Progenitor Cells: Characterization and Role in Vascular Biology

TL;DR: This review summarizes the mechanisms regulating endothelial progenitor cell–mediated neovascularization and reendothelialization and describes the characterization of the different progenitors cell populations.
Journal ArticleDOI

Number and Migratory Activity of Circulating Endothelial Progenitor Cells Inversely Correlate With Risk Factors for Coronary Artery Disease

TL;DR: Patients with CAD revealed reduced levels and functional impairment of EPCs, which correlated with risk factors for CAD, and hypertension was identified as a major independent predictor for impaired EPC migration.
Journal ArticleDOI

Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI)

TL;DR: In patients with AMI, intracoronary infusion of autologous progenitor cells appears to be feasible and safe and may beneficially affect postinfarction remodeling processes.
Journal ArticleDOI

Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction.

TL;DR: Intracoronary administration of BMC is associated with improved recovery of left ventricular contractile function in patients with acute myocardial infarction and large-scale studies are warranted to examine the potential effects of progenitor-cell administration on morbidity and mortality.